Four Thought Financial Partners, LLC Eli Lilly & CO Transaction History

Four Thought Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $403,880 - $540,334	-682 Reduced 23.57%	2,211 $1.72 Billion
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $2,100 - $2,476	4 Added 0.14%	2,893 $1.69 Billion
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $4,347 - $5,993	10 Added 0.35%	2,889 $1.55 Billion
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $48,752 - $65,188	-139 Reduced 4.61%	2,879 $1.35 Billion
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $144,442 - $169,641	465 Added 18.21%	3,018 $1.04 Billion
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $820,917 - $956,532	2,553 New	2,553 $934 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.